Daily Stock Ratings & Price Targets

Daily stock ratings from over 8,000 Wall Street analysts

Daily Buy Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Kenneth WongOppenheimer	GWRE Guidewire	BUY$230	33.16% Upside
Gaurav JainBarclays	PM Philip Morris	BUY$175	17.27% Upside
David ScharfJMP Securities	PRAA Pra Group	BUY$35	115.38% Upside
Eric HandlerRoth MKM	IMAX IMAX	BUY$32	41.78% Upside

Daily Sell Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Steven FisherUBS	CAT Caterpillar	SELL$243	-11.29% Downside
Craig MoffettMoffettNathanson	AAPL Apple	SELL$184	6.72% Upside
Jessica Reif EhrlichBank of America Securities	ATUS Altice Usa	SELL$1.5	-32.13% Downside
Ken HoexterBank of America Securities	TNK Teekay Tankers	SELL$39	13.11% Upside

Full List of Stock Ratings

(Apr 9, 2025)

Analyst Performance

Any

Analyst Rating

Any

Upside / Downside

Any

Action

Any

Market Cap

Any

Analyst & Firm	Company	Rating & Price Target	Upside / Downside	Average Return	Action	Date	Article
Richard Law CFAGoldman Sachs	VKTX Viking Therapeutics	HOLD $30	―	-1.30%	Initiated	2025-04-09	Cautious Hold Rating for Viking Therapeutics Amid Competitive Obesity Market Challenges
Reni BenjaminJMP Securities	KURA Kura Oncology	BUY $28	―	-17.20%	Reiterated	2025-04-09	Kura Oncology's Strategic Milestones and Financial Strength Bolster Buy Rating
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $32	―	11.00%	Reiterated	2025-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $42	―	4.50%	Reiterated	2025-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $35	―	11.20%	Reiterated	2025-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $175	―	5.50%	Reiterated	2025-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $202.33→$167.88	―	31.10%	Upgraded	2025-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $230	―	11.10%	Reiterated	2025-04-09
Rajan SharmaGoldman Sachs	AZN AstraZeneca	BUY $196.61	―	-10.40%	Reiterated	2025-04-09	We are Buy rated, on CL.
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $80→$70	―	5.70%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $24→$29	―	21.10%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $92	―	10.30%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $1,000	―	5.00%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $158→$125	―	5.70%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $110	―	9.80%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $146→$147	―	0.10%	Reiterated	2025-04-08
Chase KnickerbockerCraig-Hallum	CVRX CVRx	BUY $22→$14	―	-4.40%	Reiterated	2025-04-08	Craig-Hallum Reaffirms Their Buy Rating on CVRx (CVRX)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $38	―	9.90%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $133	―	9.90%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $23	―	9.90%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $230	―	1.50%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $244	―	9.90%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $235	―	1.50%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $70	―	9.90%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $540→$455	―	17.40%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $215→$190	―	17.40%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $145→$130	―	17.40%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $165→$125	―	17.40%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $4.5	―	9.70%	Initiated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $36	―	11.10%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $67	―	16.00%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $84	―	3.60%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $340→$325	―	5.70%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $170→$150	―	5.70%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $46→$35	―	7.20%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $27→$21	―	5.70%	Reiterated	2025-04-08
Dana TelseyTelsey Advisory	LEVI Levi Strauss & Co	BUY $23→$19	―	-2.70%	Reiterated	2025-04-08	Levi Strauss & Co (LEVI) Receives a Buy from Telsey Advisory
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $11→$9	―	5.70%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $170→$190	―	4.20%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $33→$34	―	6.00%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $790→$690	―	5.70%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $345→$275	―	5.70%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $260→$230	―	5.70%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $230→$190	―	5.70%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $205→$180	―	5.70%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $185→$175	―	5.70%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $180→$135	―	5.70%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $180→$125	―	5.70%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $132→$120	―	7.20%	Reiterated	2025-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $75→$60	―	5.70%	Reiterated	2025-04-08

Rows:

Ready for the Full Picture?Your current plan limits your access to top-tier analyst ratings. Subscribe to Premium now and unlock the full range of ratings from the highest-ranked analysts on Wall Street. Don't let partial views limit your market research potential - upgrade today!

Upgrade Now Plans & Pricing